XML 22 R8.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Balance Sheets (Brooklyn ImmunoTherapeutics, LLC) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Dec. 31, 2018
Current Assets:      
Prepaid expenses and other current assets $ 336,000 $ 526,000 $ 517,000
Total current assets 4,089,000 6,070,000 6,785,000
Restricted cash 201,000 50,000 50,000
Property and equipment, net 928,000 2,822,000 4,667,000
Goodwill 696,000 667,000
Total assets 6,790,000 14,125,000 14,864,000
Current Liabilities:      
Accounts payable 397,000 835,000 271,000
Current portion of lease liability 28,000 409,000
Total current liabilities 3,195,000 6,095,000 4,024,000
Lease liability, non-current 18,000 2,891,000
Total liabilities 4,859,000 9,034,000 7,947,000
Members' Equity:      
Common units 15,000 14,000 14,000
Accumulated deficit (134,706,000) (131,457,000) (129,394,000)
Total Members' Equity 1,931,000 5,091,000 6,917,000
Total liabilities and shareholders' equity 6,790,000 14,125,000 14,864,000
Brooklyn Immunotherapeutics, LLC [Member]      
Current Assets:      
Cash 5,186,675 5,014,819 6,325,431
Subscriptions receivable 500,000 850,000
Prepaid expenses and other current assets 165,842 86,668 19,998
Total current assets 5,852,517 5,101,487 7,195,429
Restricted cash 86,000 86,000
Property and equipment, net 632,303 653,763 68,099
Goodwill 2,043,747 2,043,747 2,043,747
In process research and development 6,860,000 6,860,000 6,860,000
Security deposits and other assets 448,536 363,621 379,331
Total assets 15,837,103 15,108,618 16,632,606
Current Liabilities:      
Accounts payable 1,504,983 1,735,610 2,647,532
Accrued expenses 808,632 1,520,841 1,696,793
Investor deposits 665,563 638,575
Loans payable 410,000 410,000 410,000
Current portion of lease liability 7,084 4,026
Total current liabilities 2,730,699 4,336,040 5,392,900
Lease liability, non-current 95,504 99,030
PPP loan 309,905
Other liabilities 940,769 930,445 870,000
Total liabilities 4,076,877 5,365,515 6,262,900
Commitments and Contingencies
Members' Equity:      
Common units 152,405 106,937 15,248
Accumulated deficit (13,994,184) (10,941,526) (2,004,472)
Total Members' Equity 11,760,226 9,743,103 10,369,706
Total liabilities and shareholders' equity 15,837,103 15,108,618 16,632,606
Brooklyn Immunotherapeutics, LLC [Member] | Class A Membership Units [Member]      
Members' Equity:      
Membership units 23,202,005 18,177,692 9,958,930
Brooklyn Immunotherapeutics, LLC [Member] | Class B Membership Units [Member]      
Members' Equity:      
Membership units 1,400,000 1,400,000 1,400,000
Brooklyn Immunotherapeutics, LLC [Member] | Class B Membership Units [Member]      
Members' Equity:      
Membership units $ 1,000,000 $ 1,000,000 $ 1,000,000